APA

Rao M. S., Pei Y., Garcia T. Y., Chew S., Kasai T., Hisai T., Taniguchi H., Takebe T., Lamba D. A. & Zeng X. (20190913). Illustrating the potency of current Good Manufacturing Practice-compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols. : Cytotherapy.

Chicago

Rao Mahendra S, Pei Ying, Garcia Thelma Y, Chew Shereen, Kasai Toshiharu, Hisai Tomoko, Taniguchi Hideki, Takebe Takanori, Lamba Deepak A and Zeng Xianmin. 20190913. Illustrating the potency of current Good Manufacturing Practice-compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols. : Cytotherapy.

Harvard

Rao M. S., Pei Y., Garcia T. Y., Chew S., Kasai T., Hisai T., Taniguchi H., Takebe T., Lamba D. A. and Zeng X. (20190913). Illustrating the potency of current Good Manufacturing Practice-compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols. : Cytotherapy.

MLA

Rao Mahendra S, Pei Ying, Garcia Thelma Y, Chew Shereen, Kasai Toshiharu, Hisai Tomoko, Taniguchi Hideki, Takebe Takanori, Lamba Deepak A and Zeng Xianmin. Illustrating the potency of current Good Manufacturing Practice-compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols. : Cytotherapy. 20190913.